Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program

PURPOSE: The aim of this study was to confirm the efficacy and safety of regorafenib for advanced gastrointestinal stromal tumors (GISTs) reported in the GRID phase III trial in Korean patients. MATERIALS AND METHODS: Fifty-seven Korean patientswith advanced GISTwho experienced both imatinib and sun...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Myoung Kyun, Ryu, Min-Hee, Park, Joon Oh, Im, Seock-Ah, Kim, Tae-Yong, Lee, Su Jin, Ryoo, Baek-Yeol, Park, Sook Ryun, Kang, Yoon-Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398393/
https://www.ncbi.nlm.nih.gov/pubmed/27456941
http://dx.doi.org/10.4143/crt.2016.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398393/
https://www.ncbi.nlm.nih.gov/pubmed/27456941
http://dx.doi.org/10.4143/crt.2016.067

Ejemplares similares